Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
Nivolumab
On October 4 more indications/medications/tests were approved by FDA Next-generation sequencing (NGS)-based FoundationOne CDx test as a companion diagnostic to...
